Logo for Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Investor Relations Material

Latest events

Logo for Adamis Pharmaceuticals Corporation

Q1 2023

Adamis Pharmaceuticals
Logo for Adamis Pharmaceuticals

Q3 2023

14 Nov, 2023
Logo for Adamis Pharmaceuticals

Q2 2023

21 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Adamis Pharmaceuticals Corporation

Access all reports
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing therapeutic products in allergy, respiratory, and opioid overdose treatment. Its portfolio includes prescription medicines and drug-device combination products, such as epinephrine injectors for severe allergic reactions and naloxone for opioid overdose reversal. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.